Merck to take on superbugs with Cubist Pharma buy
Merck & Co Inc said it would buy Cubist Pharmaceuticals Inc for $8.4 billion plus assumption of debt, giving the major drugmaker an entry into the market for drugs that target so-called superbugs.
Business
Pressure from competition regulators could prompt Liberty Global to abandon Germany if it can no longer pursue its growth ambitions in Europe's biggest cable market, sources have told Reuters.
The U.S. Supreme Court on Friday agreed to review a patent infringement case involving Cisco Systems Inc that could have broad impact on companies' ability to defend themselves from similar litigation.
Bankrupt U.S. companies would have more leeway to impose restructuring plans over creditors’ objections under new recommendations by a commission to overhaul Chapter 11 bankruptcy rules.
More News
